4
Changes in Ownership
UNITED THERAPEUTICS Corp Filed Acc 0001106578-26-000103
Chairperson & CEO sold 9,500 shares at an average $532.24 ($5,056,298)
- Chairperson & CEO acquired 9,500 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
ROTHBLATT MARTINE A · Chairperson & CEO
Table I: Non-derivative
12 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-07-21 | Exercise or conversion : show line 1 in the form 10b5-1 | +9,500 | $135.42 | $1,286,490 | 333,943 | I |
| 2026-07-21 | Sale : show line 2 in the form 10b5-1 | −120 | $524.37 | $62,924 | 333,823 | I |
| 2026-07-21 | Sale : show line 3 in the form 10b5-1 | −160 | $526.24 | $84,198 | 333,663 | I |
| 2026-07-21 | Sale : show line 4 in the form 10b5-1 | −240 | $527.46 | $126,590 | 333,423 | I |
| 2026-07-21 | Sale : show line 5 in the form 10b5-1 | −509 | $529.55 | $269,541 | 332,914 | I |
| 2026-07-21 | Sale : show line 6 in the form 10b5-1 | −1,926 | $530.50 | $1,021,743 | 330,988 | I |
| 2026-07-21 | Sale : show line 7 in the form 10b5-1 | −2,605 | $531.52 | $1,384,598 | 328,383 | I |
| 2026-07-21 | Sale : show line 8 in the form 10b5-1 | −360 | $532.47 | $191,688 | 328,023 | I |
| Open-market sales · 9,500 sh · avg $532.24 · $5,056,298 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-07-21 | Exercise or conversion : show line 13 in the form 10b5-1 Stock Option | −9,500 | 303,410 | I |
Loading xslF345X06/primarydocument.xml…